Postarthroscopic glenohumeral chondrolysis, also known as PAGCL, is a relatively new condition which is associated with the deterioration of cartilage in the shoulder following arthroscopic surgery. This typically occurs after an individual has had surgery on the affected shoulder. The condition generally affects the glenohumeral joint, which is the joint at the end of the shoulder comprised of the socket of the shoulder blade and the ball of the arm bone. The cartilage between these two portions of the arm and shoulder is the site affected by postarthroscopic glenohumeral chondrolysis. As the cartilage begins to deteriorate due to the condition, the individual starts to experience the complications associated with the disorder.

PAGCL is one of the most common complications following shoulder surgeries -– but it only occurs in patients who received a shoulder pain pump filled with bupivacaine and epinephrine during their surgery. In fact, studies now suggest that up to 63% of arthroscopic shoulder surgery patients who receive a post-operative pain pump may develop PAGCL.

Numerous lawsuits are pending against the companies that manufacture, market or distribute the pain pumps, including Stryker, DJO Inc., I-Flow Inc., BREG Inc. and others.

Symptoms associated with PAGCL typically manifest 3-12 months after shoulder surgery and can include: Shoulder pain whether in motion or at rest; Clicking, popping or grinding of the shoulder; Shoulder stiffness or weakness; and Decreased range of motion. Patients who are suffering from PAGCL after shoulder surgery may be entitled to legal compensation and should contact an attorney immediately.